| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 26.386 | 137.989 | 187.838 | 238.233 | 247.377 |
| Total Income - EUR | - | - | - | 0 | 0 | 26.772 | 143.018 | 192.784 | 243.143 | 253.866 |
| Total Expenses - EUR | - | - | - | 4.237 | 16.171 | 23.561 | 89.635 | 150.068 | 191.643 | 189.601 |
| Gross Profit/Loss - EUR | - | - | - | -4.237 | -16.171 | 3.210 | 53.383 | 42.716 | 51.501 | 64.265 |
| Net Profit/Loss - EUR | - | - | - | -4.237 | -16.171 | 2.947 | 51.982 | 40.837 | 49.069 | 56.697 |
| Employees | - | - | - | 2 | 3 | 3 | 4 | 2 | 4 | 0 |
Check the financial reports for the company - Dermaclas.clinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 41.753 | 40.944 | 40.168 | 35.182 | 30.203 | 25.039 | 279.129 |
| Current Assets | - | - | - | 1.231 | 1.839 | 14.057 | 40.439 | 63.857 | 53.670 | 5.691 |
| Inventories | - | - | - | 0 | 0 | 6.966 | 2.370 | 5.002 | 358 | 2.423 |
| Receivables | - | - | - | 0 | 0 | 37 | 1.482 | 56.267 | 5.211 | 3.191 |
| Cash | - | - | - | 1.231 | 1.839 | 7.054 | 36.586 | 2.588 | 1.726 | 77 |
| Shareholders Funds | - | - | - | -4.194 | -20.284 | -16.953 | 34.727 | 40.878 | 49.110 | 53.902 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 7.024 | 23.691 | 32.548 | 5.374 | 22.477 | 3.897 | 220.602 |
| Income in Advance | - | - | - | 42.978 | 42.145 | 41.346 | 35.520 | 30.705 | 25.702 | 210.280 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermaclas.clinic Srl